Roche says flexible pricing ready for cancer, not MS drugs

ZURICH, Nov 7 (Reuters) - The spotlight on finding a cancer

cure has spurred improvements in systems to collect and analyze

oncology data, but efforts to track patients with other diseases

lag...

Read more